JP2021182922A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021182922A5 JP2021182922A5 JP2021116562A JP2021116562A JP2021182922A5 JP 2021182922 A5 JP2021182922 A5 JP 2021182922A5 JP 2021116562 A JP2021116562 A JP 2021116562A JP 2021116562 A JP2021116562 A JP 2021116562A JP 2021182922 A5 JP2021182922 A5 JP 2021182922A5
- Authority
- JP
- Japan
- Prior art keywords
- hbv
- protein
- nucleotide sequence
- arenavirus
- antigenic fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023180121A JP7777907B2 (ja) | 2015-11-04 | 2023-10-19 | Ｂ型肝炎ウイルスに対するワクチン |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562250639P | 2015-11-04 | 2015-11-04 | |
| US62/250,639 | 2015-11-04 | ||
| JP2018541546A JP6914950B2 (ja) | 2015-11-04 | 2016-11-03 | Ｂ型肝炎ウイルスに対するワクチン |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018541546A Division JP6914950B2 (ja) | 2015-11-04 | 2016-11-03 | Ｂ型肝炎ウイルスに対するワクチン |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023180121A Division JP7777907B2 (ja) | 2015-11-04 | 2023-10-19 | Ｂ型肝炎ウイルスに対するワクチン |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021182922A JP2021182922A (ja) | 2021-12-02 |
| JP2021182922A5 true JP2021182922A5 (enExample) | 2022-02-01 |
Family
ID=57249796
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018541546A Active JP6914950B2 (ja) | 2015-11-04 | 2016-11-03 | Ｂ型肝炎ウイルスに対するワクチン |
| JP2021116562A Pending JP2021182922A (ja) | 2015-11-04 | 2021-07-14 | Ｂ型肝炎ウイルスに対するワクチン |
| JP2023180121A Active JP7777907B2 (ja) | 2015-11-04 | 2023-10-19 | Ｂ型肝炎ウイルスに対するワクチン |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018541546A Active JP6914950B2 (ja) | 2015-11-04 | 2016-11-03 | Ｂ型肝炎ウイルスに対するワクチン |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023180121A Active JP7777907B2 (ja) | 2015-11-04 | 2023-10-19 | Ｂ型肝炎ウイルスに対するワクチン |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US11214598B2 (enExample) |
| EP (2) | EP3371316B1 (enExample) |
| JP (3) | JP6914950B2 (enExample) |
| KR (2) | KR102832178B1 (enExample) |
| CN (2) | CN108779472B (enExample) |
| AU (3) | AU2016348675B2 (enExample) |
| CA (1) | CA3003557A1 (enExample) |
| DK (1) | DK3371316T3 (enExample) |
| ES (1) | ES2934698T3 (enExample) |
| FI (1) | FI3371316T3 (enExample) |
| HR (1) | HRP20221474T1 (enExample) |
| HU (1) | HUE060648T2 (enExample) |
| IL (2) | IL314371A (enExample) |
| LT (1) | LT3371316T (enExample) |
| MX (2) | MX2018005569A (enExample) |
| PL (1) | PL3371316T3 (enExample) |
| PT (1) | PT3371316T (enExample) |
| SG (1) | SG11201803474UA (enExample) |
| SI (1) | SI3371316T1 (enExample) |
| WO (1) | WO2017076988A1 (enExample) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103255169A (zh) | 2007-12-27 | 2013-08-21 | 苏黎士大学 | 复制缺陷型沙粒病毒载体 |
| ES2868427T3 (es) | 2013-12-03 | 2021-10-21 | Hookipa Biotech Ag | Vacunas contra el CMV |
| EP3218504B1 (en) * | 2014-11-13 | 2020-07-22 | Université de Genève | Tri-segmented arenaviruses as vaccine vectors |
| CA2987155A1 (en) | 2015-06-10 | 2016-12-15 | Hookipa Biotech Ag | Hpv vaccines |
| CA3003557A1 (en) * | 2015-11-04 | 2017-05-11 | Hookipa Biotech Ag | Vaccines against hepatitis b virus |
| US11266727B2 (en) | 2015-11-12 | 2022-03-08 | Hookipa Biotech Gmbh | Arenavirus particles as cancer vaccines |
| CN117402852A (zh) | 2016-10-14 | 2024-01-16 | 精密生物科学公司 | 对乙肝病毒基因组中的识别序列特异性的工程化大范围核酸酶 |
| JP2022010187A (ja) * | 2017-02-03 | 2022-01-14 | 株式会社三洋物産 | 遊技機 |
| JP2022010188A (ja) * | 2017-02-03 | 2022-01-14 | 株式会社三洋物産 | 遊技機 |
| EA202091517A1 (ru) | 2017-12-19 | 2020-11-03 | Янссен Сайенсиз Айрлэнд Анлимитед Компани | Способы и устройство для доставки вакцин против вируса гепатита b (hbv) |
| EA202091513A1 (ru) | 2017-12-19 | 2020-09-09 | Янссен Сайенсиз Айрлэнд Анлимитед Компани | Вакцины против вируса гепатита b (hbv) и их применение |
| EA202091516A1 (ru) | 2017-12-19 | 2020-11-03 | Янссен Сайенсиз Айрлэнд Анлимитед Компани | Способы и композиции для индукции иммунного ответа против вируса гепатита b (hbv) |
| WO2019195181A1 (en) | 2018-04-05 | 2019-10-10 | Gilead Sciences, Inc. | Antibodies and fragments thereof that bind hepatitis b virus protein x |
| US11142750B2 (en) | 2018-04-12 | 2021-10-12 | Precision Biosciences, Inc. | Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome |
| CA3143680A1 (en) * | 2019-06-18 | 2020-12-24 | Janssen Sciences Ireland Unlimited Company | Combination of hepatitis b virus (hbv) vaccines and anti-pd-1 or anti-pd-l1 antibody |
| CA3143421A1 (en) | 2019-06-18 | 2020-12-24 | Janssen Sciences Ireland Unlimited Company | Arenavirus vectors for hepatitis b virus (hbv) vaccines and uses thereof |
| MX2021015452A (es) | 2019-06-25 | 2022-02-11 | Gilead Sciences Inc | Proteinas de fusion flt3l-fc y metodos de uso. |
| IL315295A (en) | 2019-09-30 | 2024-10-01 | Gilead Sciences Inc | Hbv vaccines and methods treating hbv |
| US20220380805A1 (en) * | 2019-11-07 | 2022-12-01 | Universität Basel | Arenaviruses as vectors |
| WO2021113765A1 (en) | 2019-12-06 | 2021-06-10 | Precision Biosciences, Inc. | Optimized engineered meganucleases having specificity for a recognition sequence in the hepatitis b virus genome |
| EP4445902A3 (en) | 2019-12-24 | 2024-12-18 | Carna Biosciences, Inc. | Diacylglycerol kinase modulating compounds |
| JP2023518433A (ja) | 2020-03-20 | 2023-05-01 | ギリアード サイエンシーズ， インコーポレイテッド | ４’－ｃ－置換－２－ハロ－２’－デオキシアデノシンヌクレオシドのプロドラッグ並びにその製造法及び使用法 |
| KR102375703B1 (ko) | 2020-07-28 | 2022-03-17 | 경북대학교 산학협력단 | 사물 인터넷 환경에서 CoAP 기반의 데이터 스트리밍 방법 및 통신 시스템 |
| WO2022200373A2 (en) | 2021-03-23 | 2022-09-29 | Hookipa Biotech Gmbh | Arenaviruses used in treatments of prostate cancer |
| WO2022226242A1 (en) * | 2021-04-21 | 2022-10-27 | La Jolla Institute For Immunology | Engineered arenavirus glycoprotein compositions, methods and use thereof |
| CN113201051B (zh) * | 2021-04-27 | 2022-08-02 | 复旦大学 | 一种乙肝病毒表面蛋白突变体及其在抗乙肝病毒中的应用 |
| TW202310852A (zh) | 2021-05-13 | 2023-03-16 | 美商基利科學股份有限公司 | ＴＬＲ８調節化合物及抗ＨＢＶ ｓｉＲＮＡ療法之組合 |
| KR20240023629A (ko) | 2021-06-23 | 2024-02-22 | 길리애드 사이언시즈, 인코포레이티드 | 디아실글리세롤 키나제 조절 화합물 |
| EP4359411A1 (en) | 2021-06-23 | 2024-05-01 | Gilead Sciences, Inc. | Diacylglyercol kinase modulating compounds |
| KR20240005901A (ko) | 2021-06-23 | 2024-01-12 | 길리애드 사이언시즈, 인코포레이티드 | 디아실글리세롤 키나제 조절 화합물 |
| CR20230585A (es) | 2021-06-23 | 2024-02-19 | Gilead Sciences Inc | Compuestos Moduladores de Diacilglicerol Quinasa. |
| WO2025056782A1 (en) | 2023-09-15 | 2025-03-20 | Hookipa Biotech Gmbh | Arenavirus formulations, methods and uses thereof |
| US20250345390A1 (en) | 2024-05-13 | 2025-11-13 | Gilead Sciences, Inc. | Combination therapies |
| WO2025240242A1 (en) | 2024-05-13 | 2025-11-20 | Gilead Sciences, Inc. | Combination therapies with ribavirin |
| WO2025240246A1 (en) | 2024-05-13 | 2025-11-20 | Gilead Sciences, Inc. | Combination therapies with ribavirin |
| US20250345389A1 (en) | 2024-05-13 | 2025-11-13 | Gilead Sciences, Inc. | Combination therapies |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4722840A (en) * | 1984-09-12 | 1988-02-02 | Chiron Corporation | Hybrid particle immunogens |
| US5057540A (en) | 1987-05-29 | 1991-10-15 | Cambridge Biotech Corporation | Saponin adjuvant |
| US4912094B1 (en) | 1988-06-29 | 1994-02-15 | Ribi Immunochem Research Inc. | Modified lipopolysaccharides and process of preparation |
| JPH1084967A (ja) * | 1996-09-19 | 1998-04-07 | Fujirebio Inc | Ｂ型肝炎のｅ抗原 |
| EP2360174B1 (en) * | 1998-12-04 | 2014-04-09 | Biogen Idec MA Inc. | HBV core antigen particles with multiple immunogenic components attached via peptide ligands |
| FR2803599B1 (fr) * | 2000-01-06 | 2004-11-19 | Inst Nat Sante Rech Med | Nouveau virus mute de l'hepatite b, ses constituants nucleiques et proteiques et leurs applications |
| US20100183652A1 (en) * | 2002-02-21 | 2010-07-22 | Mark Page | STABILIZED HBc CHIMER PARTICLES AS THERAPEUTIC VACCINE FOR CHRONIC HEPATITIS |
| EP1888622A1 (en) | 2005-05-23 | 2008-02-20 | Oxxon Therapeutics Ltd. | Compositions for inducing an immune response against hepatitis b |
| CN101037476A (zh) * | 2006-03-15 | 2007-09-19 | 复旦大学 | 一种用于制备抗体化乙肝疫苗的融合蛋白及其载体 |
| EP2007765B1 (en) | 2006-03-23 | 2012-06-27 | Novartis AG | Immunopotentiating compounds |
| ATE539079T1 (de) | 2006-03-23 | 2012-01-15 | Novartis Ag | Imidazochinoxalinverbindungen als immunmodulatoren |
| WO2008083174A2 (en) * | 2006-12-27 | 2008-07-10 | Emory University | Compositions and methods for the treatment of infections and tumors |
| CN103255169A (zh) * | 2007-12-27 | 2013-08-21 | 苏黎士大学 | 复制缺陷型沙粒病毒载体 |
| NZ598000A (en) | 2009-08-07 | 2013-10-25 | Transgene Sa | Composition for treating hbv infection |
| US10076570B2 (en) * | 2009-08-07 | 2018-09-18 | Transgene S.A. | Composition for treating HBV infection |
| PH12013501683A1 (en) * | 2011-02-12 | 2019-07-17 | Globeimmune Inc | Yeast-based therapeutic for chronic hepatitis b infection |
| WO2012162428A1 (en) | 2011-05-23 | 2012-11-29 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Prime-boost vaccination for viral infection |
| IN2014DN06118A (enExample) | 2012-01-24 | 2015-08-14 | Sanford Res Usd | |
| ES2751423T3 (es) | 2013-03-15 | 2020-03-31 | Univ Geneve | Vacunas antimicobacterianas |
| GB201305361D0 (en) | 2013-03-25 | 2013-05-08 | Univ Edinburgh | Enhanced expression |
| ES2868427T3 (es) | 2013-12-03 | 2021-10-21 | Hookipa Biotech Ag | Vacunas contra el CMV |
| US10342861B2 (en) | 2014-05-27 | 2019-07-09 | University Of Rochester | Arenavirus vaccine |
| US9943585B2 (en) | 2014-07-30 | 2018-04-17 | University Of Rochester | Methods and compositions related to reorganization of arenavirus genome for development of novel arenavirus live-attenuated vaccines (LAV) |
| JP6875274B6 (ja) | 2014-09-22 | 2021-06-30 | リージェンツ オブ ザ ユニバーシティ オブ ミネソタ | ピチンデウイルスのリバースジェネティクス系及び使用方法 |
| GB201419572D0 (en) | 2014-11-03 | 2014-12-17 | Pirbright Inst The | Virus |
| EP3218504B1 (en) * | 2014-11-13 | 2020-07-22 | Université de Genève | Tri-segmented arenaviruses as vaccine vectors |
| DE102015207036A1 (de) | 2015-04-17 | 2016-10-20 | Karl Sebastian Lang | Arenaviren zur Anwendung bei der Behandlung und/oder Vorbeugung von Tumoren sowie Verfahren zur Herstellung von Arenaviren mit (verbesserten) tumorregressiven Eigenschaften |
| CA2987155A1 (en) | 2015-06-10 | 2016-12-15 | Hookipa Biotech Ag | Hpv vaccines |
| WO2017068190A1 (en) | 2015-10-23 | 2017-04-27 | Institut Pasteur | Recombinant mopeia virus and vaccine platform |
| CA3003557A1 (en) | 2015-11-04 | 2017-05-11 | Hookipa Biotech Ag | Vaccines against hepatitis b virus |
| US11266727B2 (en) | 2015-11-12 | 2022-03-08 | Hookipa Biotech Gmbh | Arenavirus particles as cancer vaccines |
| WO2017190074A1 (en) | 2016-04-28 | 2017-11-02 | The University Of Chicago | Lymphangiogenesis for therapeutic immunomodulation |
| NZ788311A (en) | 2016-05-18 | 2025-11-28 | Univ Basel | Tri-segmented pichinde viruses as vaccine vectors |
| AU2017353443B2 (en) | 2016-11-04 | 2024-11-14 | Hookipa Biotech Gmbh | Replication-deficient arenavirus particles and tri-segmented arenavirus particles as cancer vaccines |
| EP3606549A1 (en) | 2017-04-07 | 2020-02-12 | Hookipa Biotech GmbH | Arenavirus particles to treat solid tumors |
-
2016
- 2016-11-03 CA CA3003557A patent/CA3003557A1/en active Pending
- 2016-11-03 KR KR1020187015548A patent/KR102832178B1/ko active Active
- 2016-11-03 PL PL16791573.5T patent/PL3371316T3/pl unknown
- 2016-11-03 ES ES16791573T patent/ES2934698T3/es active Active
- 2016-11-03 EP EP16791573.5A patent/EP3371316B1/en active Active
- 2016-11-03 CN CN201680077751.0A patent/CN108779472B/zh active Active
- 2016-11-03 AU AU2016348675A patent/AU2016348675B2/en active Active
- 2016-11-03 LT LTEPPCT/EP2016/076591T patent/LT3371316T/lt unknown
- 2016-11-03 EP EP22201924.2A patent/EP4177348A1/en active Pending
- 2016-11-03 DK DK16791573.5T patent/DK3371316T3/da active
- 2016-11-03 SG SG11201803474UA patent/SG11201803474UA/en unknown
- 2016-11-03 IL IL314371A patent/IL314371A/en unknown
- 2016-11-03 US US15/773,512 patent/US11214598B2/en active Active
- 2016-11-03 MX MX2018005569A patent/MX2018005569A/es unknown
- 2016-11-03 WO PCT/EP2016/076591 patent/WO2017076988A1/en not_active Ceased
- 2016-11-03 CN CN202211051785.6A patent/CN115948467A/zh active Pending
- 2016-11-03 SI SI201631654T patent/SI3371316T1/sl unknown
- 2016-11-03 HU HUE16791573A patent/HUE060648T2/hu unknown
- 2016-11-03 JP JP2018541546A patent/JP6914950B2/ja active Active
- 2016-11-03 HR HRP20221474TT patent/HRP20221474T1/hr unknown
- 2016-11-03 FI FIEP16791573.5T patent/FI3371316T3/fi active
- 2016-11-03 PT PT167915735T patent/PT3371316T/pt unknown
- 2016-11-03 KR KR1020257022585A patent/KR20250107977A/ko active Pending
- 2016-11-03 IL IL259077A patent/IL259077B2/en unknown
-
2018
- 2018-05-03 MX MX2023013140A patent/MX2023013140A/es unknown
-
2021
- 2021-07-14 JP JP2021116562A patent/JP2021182922A/ja active Pending
- 2021-11-24 US US17/535,121 patent/US20220073568A1/en not_active Abandoned
-
2023
- 2023-01-10 AU AU2023200108A patent/AU2023200108B2/en active Active
- 2023-10-19 JP JP2023180121A patent/JP7777907B2/ja active Active
-
2025
- 2025-11-24 AU AU2025271193A patent/AU2025271193A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021182922A5 (enExample) | ||
| JP2018536433A5 (enExample) | ||
| FI3371316T3 (fi) | Rokotteita hepatiitti b -virusta vastaan | |
| JP2021061848A5 (enExample) | ||
| Combredet et al. | A molecularly cloned Schwarz strain of measles virus vaccine induces strong immune responses in macaques and transgenic mice | |
| Dietzschold et al. | New approaches to the prevention and eradication of rabies | |
| Beard et al. | Development of DNA vaccines for foot-and-mouth disease, evaluation of vaccines encoding replicating and non-replicating nucleic acids in swine | |
| JP2017503482A5 (enExample) | ||
| JP2017535267A5 (enExample) | ||
| KR100996330B1 (ko) | Ｈｉｖ 조절/부속 단백질의 융합 단백질 | |
| Fischer et al. | Novel recombinant parapoxvirus vectors induce protective humoral and cellular immunity against lethal herpesvirus challenge infection in mice | |
| JPH03216186A (ja) | キメラヘパドナウイルスコア抗原蛋白 | |
| HRP20211015T1 (hr) | Cjepivo protiv citomegalovirusa (cmv) | |
| JP2014516536A5 (enExample) | ||
| JPH08168381A (ja) | 組換え伝染性非セグメント化陰性鎖ｒｎａウイルス | |
| JP2013501038A5 (enExample) | ||
| JP2004501646A5 (enExample) | ||
| JP5675789B2 (ja) | 免疫接種のための発現ベクターとしての水疱性口内炎ウイルスの異なる複数の抗原型 | |
| JP2011523642A5 (enExample) | ||
| JP2018533908A5 (enExample) | ||
| CN113430178B (zh) | 一种表达ii型单纯疱疹病毒蛋白的重组流感病毒株及其制备方法与应用 | |
| JP2020522249A5 (enExample) | ||
| Kim et al. | Application of attenuated coxsackievirus B3 as a viral vector system for vaccines and gene therapy | |
| JP6373601B2 (ja) | アカバネウイルスに対して中和活性を有する抗体を誘導するペプチド | |
| Roberts et al. | Redesign and genetic dissection of the rhabdoviruses |